Surya Bhatt, MD: Findings on Dupilumab for Patients with COPD, Type 2 Inflammation
In this Q&A discussion, Bhatt discusses the recent news of dupilumab’s supplemental Biologics License Application for COPD patients with type 2 inflammation, as well as its significance.